Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination.

MLA

Horrevorts, Sophie K., et al. “Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination.” Cancers, vol. 11, no. 9, Sept. 2019, p. 1266. EBSCOhost, https://doi.org/10.3390/cancers11091266.

APA

Horrevorts, S. K., Stolk, D. A., van de Ven, R., Hulst, M., van Het Hof, B., Duinkerken, S., Heineke, M. H., Ma, W., Dusoswa, S. A., Nieuwland, R., Garcia-Vallejo, J. J., van de Loosdrecht, A. A., de Gruijl, T. D., van Vliet, S. J., & van Kooyk, Y. (2019). Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination. Cancers, 11(9), 1266. https://doi.org/10.3390/cancers11091266

Chicago

Horrevorts, Sophie K., Dorian A. Stolk, Rieneke van de Ven, Myrthe Hulst, Bert van Het Hof, Sanne Duinkerken, Marieke H. Heineke, et al. 2019. “Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination.” Cancers 11 (9): 1266. doi:10.3390/cancers11091266.